avoralstat
BCX4161-111
Phase 1 small_molecule terminated
Quick answer
avoralstat for Diabetic Macular Edema (DME) is a Phase 1 program (small_molecule) at BIOCRYST PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BIOCRYST PHARMACEUTICALS INC
- Indication
- Diabetic Macular Edema (DME)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated